FDA approves Pfizer’s RSV vaccine for adults age 60 and older
Why it matters: Older adults are at higher risk. Each year, about 60,000 adults ages 65 and older are hospitalized with RSV, and about 6,000… Read More »FDA approves Pfizer’s RSV vaccine for adults age 60 and older